Powering Biotech Growth Through Capital and Pharma Partnerships
Bringing together biotech founders and executives, active investors, and pharma leaders to drive funding, partnering, and growth.
What is LSX Congress USA?
LSX Congress USA is where biotech companies at different stages of growth come to meet the investors and pharma partners who can help shape what comes next. From emerging biotechs seeking capital and visibility to later-stage companies pursuing strategic partnerships and commercial momentum, the event is built around the conversations that matter most.
Capital to support the next stage of growth
From emerging biotechs preparing for seed to Series A/B conversations to later-stage companies looking to strengthen their funding strategy, LSX Congress USA is designed to connect companies with active investors and the insight needed to move forward with confidence.
Pharma partnerships with strategic value
For biotechs looking beyond capital, LSX Congress USA creates opportunities to connect with pharma leaders around partnering, licensing and long-term strategic growth. It is built to support the conversations that help companies move from innovation to execution.
Focused visibility, partnering and momentum
With targeted 1:1 partnering, dedicated biotech startup and growth showcases, and content tailored to the priorities of biotech leaders, LSX Congress USA offers a focused platform for companies that want to raise their profile, meet the right people and accelerate what comes next.
Take a look at who spoke at LSX USA 2026...
Focused Content
Early Innovation & Technology Translation
This track focuses on the latest breakthroughs in biotech innovation and the strategies to translate cutting-edge discoveries into impactful solutions. It explores the journey from early-stage research to development, highlighting advancements in biotechnology. Key discussions include fostering academic-industry collaborations, navigating regulatory pathways, and accelerating the commercialization of early-stage biotech innovations.
Capital Markets & Investment Strategies
This track delves into the financial landscape of the biotech sector, offering insights into capital markets, funding trends, and investment strategies. It covers topics such as venture capital, private equity, IPOs, and M&A activity, providing actionable advice for securing funding and scaling biotech businesses. Attendees will gain a deeper understanding of how to align financial strategies with market dynamics and investor expectations.
Pharma Partnering & Deal Making
This track examines the critical role of partnerships and collaborations in driving growth and innovation in the biotech and pharmaceutical industries. It focuses on deal-making strategies, licensing agreements, and co-development opportunities. Attendees will learn how to identify the right partners, negotiate successful deals, and leverage alliances to bring new biotech therapies to market faster and more efficiently.
Market Opportunities & Commercialisation
This track addresses the challenges and opportunities in bringing biotech products to market. It covers market access, pricing strategies, and commercialization pathways for biopharma solutions. Discussions will include navigating global markets, understanding payer dynamics, and optimizing go-to-market strategies to maximize product impact and revenue potential.
The numbers that matter
1000+
Senior Attendees
250+
Investors
180+
Expert Speakers
2000+
1:1 Partnering Meetings
3
Forums & Workshops
5
Streams
Sustain your connection with the Life Sciences eXecutive partnering community
Whether you're increasing your company profile, launching a new product, or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
To begin building your custom sponsorship package today, contact us directly:
Our 2026 Sponsors
Maria Shepherd
President
Medi-Vantage LLC
LSX knows its audience, investors, strategic partners and start ups. They do a great job of meeting their needs.
How can LSX help you?
Intelligence
Acting as an active conduit of industry insights, innovation, trends, best practices & benchmarking
Investment
Leveraging our extensive network we help match life science innovators with the right investors
Community
Organising formal and informal opportunities to foster connections through networking and serendipitous meetings
FAQs
What is LSX Congress USA?
LSX Congress USA is a leading event focusing on the US and life sciences sector, bringing together biotech leaders, pharma executives and active investors.
Designed for companies raising capital, pursuing strategic partnerships and preparing for their next phase of growth, the event connects founders, CEOs and senior executives with the people and opportunities that can help move their business forward. Through high-quality content, targeted networking, 1:1 partnering and investor engagement, LSX Congress USA supports biotech companies in building relationships, securing funding and advancing strategic goals.
Whether you are an early-stage biotech or a more established company looking to connect with pharma, LSX Congress USA is a gateway to the partnerships and conversations that drive growth.
Where and when is LSX Congress USA being held?
LSX Congress USA takes place 23-24 September 2026 at the Hynes Convention Center, Boston, USA.
It forms part of Biotech Week Boston, which brings together multiple life science events in the city from 22–25 September 2026.
Who attends LSX Congress USA?
LSX Congress USA brings together a senior and influential audience from across the US life sciences ecosystem. Attendees include biotech founders, CEOs and executive teams, active investors, pharma leaders, and specialist partners supporting company growth. From fundraising and strategic partnerships to investment and business development, the event is designed to connect the people driving the next phase of life science innovation.
- C-suite executives: CEOs, CFOs, COOs, and other senior leaders driving strategy and decision-making.
- Founders and entrepreneurs: Visionaries leading innovative biotech companies.
- Investors and venture capitalists: Active life science investors seeking high-potential companies, investment opportunities and new syndication or partnering conversations.
- Pharma leaders and strategic partners: Pharma executives, business development leaders and partnering teams looking to source innovation, assess opportunities and build relationships with biotech companies.
- Specialist partners and service providers: Organizations offering expertise, resources, and solutions to support business growth.
What companies are speaking at LSX Congress USA?
Our speaking programme features speakers from a diverse mix of biopharmaceutical, pharmaceutical, and corporate venture capital firms. Including:
Boehringer Ingelheim
Ipsen
Johnson & Johnson
Blackstone LIfe Sciences
GSK
Eli Lilly
Angelini Ventures
AbbVie
Servier
Vida Ventures
What is the format and what to expect?
A Pre-Day on Septemeber 22, 2026 focuses on CEO and Partnering Forums as closed-door roundtable discussions - View Pre-Day Agenda here.
The main event is held over two days (September 23 - 24, 2026) with the following:
- Opportunities to present your company, pitch to investors and pharma
- Qualified 1:1 partnering as a core feature to facilitate deal conversations
- Thought leadership and expert speakers: sessions with interactive Q&A, panel discussions with industry leaders, and real-world case studies and practical frameworks
- Networking breaks and evening receptions
Is LSX Congress USA suitable for start-ups and later stage companies?
Absolutely! LSX Congress USA is suitable for both start-ups and later-stage companies. From early-stage biotechs navigating fundraising and investor outreach to more established businesses pursuing strategic partnerships and commercial growth, the event is designed to connect companies with the investors, pharma leaders and expert partners who can help move them forward.
As an investor attending LSX Congress USA what should I focus on?
- Securing targeted 1:1 meetings with the biotech companies, pharma teams and fellow investors most relevant to your investment focus
- Using the showcase presentations to assess companies quickly and spot those with strong investor potential
- Tracking current fundraising trends, market sentiment and partnering activity through the agenda
- Attend the Investor Syndacation Reception to build relationships that can support future syndication, strategic partnerships and long-term dealflow
How do I qualify for an Investor Pass?
Please check our terms and conditions on the Investor Qualification page below:
How can I make the most at LSX Congress USA as a biotech CEO?
Here’s some tips:
- Prepare a short “elevator pitch” summarising your company, value creation plan.
- Research the investors and pharma companies who will be attending and prioritise networking with them.
- Attend sessions relevant to your growth stage and market focus.
- Use partnering app to pre-book 1:1 meetings early to secure time with investors and partners.
- Be visible – Ask questions in panels that show you are thinking about commercial strategy/market access, engage in networking breaks and showcase opportunities.
- Follow up quickly to turn new connections into lasting relationships.
Who organizes LSX Congress USA?
LSX Congress USA is organized by Informa Connect, part of Informa PLC.
Contact us
We do not share any data without consent
Outside vendors who contact you to sell attendee lists are operating independently and without approval of the event organisers.